Web Analytics

3 Latest Announced Rounds

  • $10,500,000
    Series A

    6 Investors

    Chemical Manufacturing
    Nov 15th, 2024
  • $3,000,000
    Pre-Seed

    1 Investors

    Software Development
    Nov 15th, 2024
  • $1,600,000
    Pre-Seed

    3 Investors

    Software Development
    Nov 15th, 2024
$1,512.09M Raised in 74 Funding Rounds in the past 7 Days - View All

Funding Round Profile

NAPIGEN, INC.

start up
United States - Wilmington, DE
  • 12/07/2022
  • Seed
  • $7,900,000

NAPIGEN is a biotechnology company that addresses novel genome engineering of various organisms such as plants, microbes and animals. Our technology targets two special cellular components known as organelles that harbor their own DNA. Those organelles are called mitochondria and chloroplasts. Both organelles are important to create energy for cells to grow. They are also critical for producing various biochemical molecules key to specific pathways and functions. Our genome technology has broad application areas. They range from industrial biotechnology to animal and human healthcare as well as to agriculture. Our mission is to harness the potentials of organelles to make our society a better place to live.


Related People

Hajime SakaiCo Founder

Hajime Sakai United States - Greater Philadelphia

Boys & girls - Be ambitious for our plant!